188 related articles for article (PubMed ID: 18763031)
21. CYP1B1, but not CYP1A1, is downregulated by promoter methylation in colorectal cancers.
Habano W; Gamo T; Sugai T; Otsuka K; Wakabayashi G; Ozawa S
Int J Oncol; 2009 Apr; 34(4):1085-91. PubMed ID: 19287966
[TBL] [Abstract][Full Text] [Related]
22. Association of genetic variants of xenobiotic and estrogen metabolism pathway (CYP1A1 and CYP1B1) with gallbladder cancer susceptibility.
Sharma KL; Agarwal A; Misra S; Kumar A; Kumar V; Mittal B
Tumour Biol; 2014 Jun; 35(6):5431-9. PubMed ID: 24535777
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms of the CYP1B1 gene may be associated with the onset of natural menopause in Chinese women.
Long JR; Shu XO; Cai Q; Cai H; Gao YT; Jin F; Zheng W
Maturitas; 2006 Oct; 55(3):238-46. PubMed ID: 16766147
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms in CYP1A1, CYP1B1 and COMT genes in Greenlandic Inuit and Europeans.
Ghisari M; Long M; Bonefeld-Jørgensen EC
Int J Circumpolar Health; 2013; 72():21113. PubMed ID: 23785672
[TBL] [Abstract][Full Text] [Related]
26. Association of the CYP17 gene polymorphism with risk for uterine leiomyoma in Brazilian women.
Vieira LC; Gomes MT; Castro Rde A; de Souza NC; da Silva ID; Baracat EC; Girão MJ
Gynecol Endocrinol; 2008 Jul; 24(7):373-7. PubMed ID: 18645709
[TBL] [Abstract][Full Text] [Related]
27. The CYP17 MspA1 polymorphism is not associated with an increased risk of uterine leiomyomas in a Japanese population.
Tsujino T; Ohara N; Yoshida S; Kennedy S; Takemura N; Deguchi M; Maruo T
Gynecol Endocrinol; 2006 Feb; 22(2):87-91. PubMed ID: 16603433
[TBL] [Abstract][Full Text] [Related]
28. The -2549 insertion/deletion polymorphism of VEGF gene associated with uterine leiomyoma susceptibility in women from Southeastern Iran.
Keshavarzi F; Salimi S; Mohammadpour-Gharehbagh A; Teimoori B; Yazdi A; Farajian-Mashhadi F; Yaghmaei M; Mokhtari M
Ginekol Pol; 2017; 88(3):115-119. PubMed ID: 28397198
[TBL] [Abstract][Full Text] [Related]
29. Lack of association between the functional polymorphisms in the estrogen-metabolizing genes and risk for hepatocellular carcinoma.
Yuan X; Zhou G; Zhai Y; Xie W; Cui Y; Cao J; Zhi L; Zhang H; Yang H; Zhang X; Qiu W; Peng Y; Zhang X; Yu L; Xia X; He F
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3621-7. PubMed ID: 19064581
[TBL] [Abstract][Full Text] [Related]
30. G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk.
Kasap B; Öztürk Turhan N; Edgünlü T; Duran M; Akbaba E; Öner G
Bosn J Basic Med Sci; 2016 Jan; 16(1):39-45. PubMed ID: 26773178
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor alpha polymorphism and susceptibility to uterine leiomyoma.
Villanova FE; Andrade PM; Otsuka AY; Gomes MT; Leal ES; Castro RA; Girão MJ; Nishimura E; Baracat EC; Silva ID
Steroids; 2006 Nov; 71(11-12):960-5. PubMed ID: 16935316
[TBL] [Abstract][Full Text] [Related]
32. Association of CYP1A1 and CYP1B1 polymorphisms with bone mineral density variations in postmenopausal Mexican-Mestizo women.
Chávez B; Vilchis F; Rojano-Mejía D; Coral Vázquez RM; Aguirre-García MDC; Canto P
Gynecol Endocrinol; 2017 Aug; 33(8):607-610. PubMed ID: 28300467
[TBL] [Abstract][Full Text] [Related]
33. Studies on CYP1A1, CYP1B1 and CYP3A4 gene polymorphisms in breast cancer patients.
Ociepa-Zawal M; Rubiś B; Filas V; Breborowicz J; Trzeciak WH
Ginekol Pol; 2009 Nov; 80(11):819-23. PubMed ID: 20088394
[TBL] [Abstract][Full Text] [Related]
34. Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss.
Saijo Y; Sata F; Yamada H; Suzuki K; Sasaki S; Kondo T; Gong YY; Kato EH; Shimada S; Morikawa M; Minakami H; Kishi R
Mol Hum Reprod; 2004 Oct; 10(10):729-33. PubMed ID: 15299091
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of six different polymorphic CYP1B1 enzyme variants found in an Ethiopian population.
Aklillu E; Oscarson M; Hidestrand M; Leidvik B; Otter C; Ingelman-Sundberg M
Mol Pharmacol; 2002 Mar; 61(3):586-94. PubMed ID: 11854439
[TBL] [Abstract][Full Text] [Related]
36. Haplotypes of CYP1B1 and CCDC57 genes in an Afro-Caribbean female population with uterine leiomyoma.
Alleyne AT; Bideau VS
Mol Biol Rep; 2019 Jun; 46(3):3299-3306. PubMed ID: 30989560
[TBL] [Abstract][Full Text] [Related]
37. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
38. Expression of dioxin-related transactivating factors and target genes in human eutopic endometrial and endometriotic tissues.
Bulun SE; Zeitoun KM; Kilic G
Am J Obstet Gynecol; 2000 Apr; 182(4):767-75. PubMed ID: 10764452
[TBL] [Abstract][Full Text] [Related]
39. Interaction between cytochrome P450 gene polymorphisms and serum organochlorine TEQ levels in the risk of endometriosis.
Tsuchiya M; Tsukino H; Iwasaki M; Sasaki H; Tanaka T; Katoh T; Patterson DG; Turner W; Needham L; Tsugane S
Mol Hum Reprod; 2007 Jun; 13(6):399-404. PubMed ID: 17449539
[TBL] [Abstract][Full Text] [Related]
40. Polymorphic variation of CYP1A1 and CYP1B1 genes in a Haryana population.
Giri SK; Yadav A; Kumar A; Dev K; Gulati S; Gupta R; Aggarwal N; Gautam SK
Biochem Genet; 2013 Dec; 51(11-12):853-64. PubMed ID: 23839087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
